Biopharmaceuticals-EMEA Market Status and Trend Report 2013-2023
SKU ID :MI-11647006 | Published Date: 21-May-2018 | No. of pages: 154Description
TOC
Table of Contents
Chapter 1 Overview of Biopharmaceuticals
1.1 Definition of Biopharmaceuticals in This Report
1.2 Commercial Types of Biopharmaceuticals
1.2.1 Monoclonal Antibodies
1.2.2 Interferon
1.2.3 Colony-Stimulating Factor
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Growth Hormones
1.2.8 Other
1.3 Downstream Application of Biopharmaceuticals
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Other
1.4 Development History of Biopharmaceuticals
1.5 Market Status and Trend of Biopharmaceuticals 2013-2023
1.5.1 EMEA Biopharmaceuticals Market Status and Trend 2013-2023
1.5.2 Regional Biopharmaceuticals Market Status and Trend 2013-2023
Chapter 2 EMEA Market Status and Forecast by Regions
2.1 Market Status of Biopharmaceuticals in EMEA 2013-2017
2.2 Consumption Market of Biopharmaceuticals in EMEA by Regions
2.2.1 Consumption Volume of Biopharmaceuticals in EMEA by Regions
2.2.2 Revenue of Biopharmaceuticals in EMEA by Regions
2.3 Market Analysis of Biopharmaceuticals in EMEA by Regions
2.3.1 Market Analysis of Biopharmaceuticals in Europe 2013-2017
2.3.2 Market Analysis of Biopharmaceuticals in Middle East 2013-2017
2.3.3 Market Analysis of Biopharmaceuticals in Africa 2013-2017
2.4 Market Development Forecast of Biopharmaceuticals in EMEA 2018-2023
2.4.1 Market Development Forecast of Biopharmaceuticals in EMEA 2018-2023
2.4.2 Market Development Forecast of Biopharmaceuticals by Regions 2018-2023
Chapter 3 EMEA Market Status and Forecast by Types
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Biopharmaceuticals in EMEA by Types
3.1.2 Revenue of Biopharmaceuticals in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Biopharmaceuticals in EMEA by Types
Chapter 4 EMEA Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Biopharmaceuticals in EMEA by Downstream Industry
4.2 Demand Volume of Biopharmaceuticals by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biopharmaceuticals by Downstream Industry in Europe
4.2.2 Demand Volume of Biopharmaceuticals by Downstream Industry in Middle East
4.2.3 Demand Volume of Biopharmaceuticals by Downstream Industry in Africa
4.3 Market Forecast of Biopharmaceuticals in EMEA by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Biopharmaceuticals
5.1 EMEA Economy Situation and Trend Overview
5.2 Biopharmaceuticals Downstream Industry Situation and Trend Overview
Chapter 6 Biopharmaceuticals Market Competition Status by Major Players in EMEA
6.1 Sales Volume of Biopharmaceuticals in EMEA by Major Players
6.2 Revenue of Biopharmaceuticals in EMEA by Major Players
6.3 Basic Information of Biopharmaceuticals by Major Players
6.3.1 Headquarters Location and Established Time of Biopharmaceuticals Major Players
6.3.2 Employees and Revenue Level of Biopharmaceuticals Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Biopharmaceuticals Major Manufacturers Introduction and Market Data
7.1 Roche
7.1.1 Company profile
7.1.2 Representative Biopharmaceuticals Product
7.1.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Roche
7.2 Amgen
7.2.1 Company profile
7.2.2 Representative Biopharmaceuticals Product
7.2.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Amgen
7.3 AbbVie
7.3.1 Company profile
7.3.2 Representative Biopharmaceuticals Product
7.3.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of AbbVie
7.4 Sanofi-Aventis
7.4.1 Company profile
7.4.2 Representative Biopharmaceuticals Product
7.4.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Sanofi-Aventis
7.5 Johnson & Johnson
7.5.1 Company profile
7.5.2 Representative Biopharmaceuticals Product
7.5.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.6 Pfizer
7.6.1 Company profile
7.6.2 Representative Biopharmaceuticals Product
7.6.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Pfizer
7.7 Novo Nordisk
7.7.1 Company profile
7.7.2 Representative Biopharmaceuticals Product
7.7.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Novo Nordisk
7.8 Eli Lilly
7.8.1 Company profile
7.8.2 Representative Biopharmaceuticals Product
7.8.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Eli Lilly
7.9 Novartis
7.9.1 Company profile
7.9.2 Representative Biopharmaceuticals Product
7.9.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Novartis
7.10 Merck
7.10.1 Company profile
7.10.2 Representative Biopharmaceuticals Product
7.10.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Merck
Chapter 8 Upstream and Downstream Market Analysis of Biopharmaceuticals
8.1 Industry Chain of Biopharmaceuticals
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Biopharmaceuticals
9.1 Cost Structure Analysis of Biopharmaceuticals
9.2 Raw Materials Cost Analysis of Biopharmaceuticals
9.3 Labor Cost Analysis of Biopharmaceuticals
9.4 Manufacturing Expenses Analysis of Biopharmaceuticals
Chapter 10 Marketing Status Analysis of Biopharmaceuticals
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
Tables & Figures
List of Tables
Table Advantage and Disadvantage of Monoclonal Antibodies
Table Advantage and Disadvantage of Interferon
Table Advantage and Disadvantage of Colony-Stimulating Factor
Table Advantage and Disadvantage of Erythropoietin
Table Advantage and Disadvantage of Insulin
Table Advantage and Disadvantage of Vaccines
Table Advantage and Disadvantage of Growth Hormones
Table Advantage and Disadvantage of Other
Table Consumption Volume of Biopharmaceuticals in EMEA by Regions 2013-2017
Table Revenue of Biopharmaceuticals in EMEA by Regions 2013-2017
Table Consumption Volume of Biopharmaceuticals in EMEA by Regions 2018-2023
Table Revenue of Biopharmaceuticals in EMEA by Regions 2018-2023
Table Consumption Volume of Biopharmaceuticals in EMEA by Types 2013-2017
Table Revenue of Biopharmaceuticals in EMEA by Types 2013-2017
Table Consumption Volume of Biopharmaceuticals by Types in Europe 2013-2017
Table Consumption Volume of Biopharmaceuticals by Types in Middle East 2013-2017
Table Consumption Volume of Biopharmaceuticals by Types in Africa 2013-2017
Table Consumption Volume Forecast of Biopharmaceuticals in EMEA by Types 2018-2023
Table Revenue Forecast of Biopharmaceuticals in EMEA by Types 2018-2023
Table Demand Volume of Biopharmaceuticals in EMEA by Downstream Industry 2013-2017
Table Demand Volume of Biopharmaceuticals by Downstream Industry in Europe 2013-2017
Table Demand Volume of Biopharmaceuticals by Downstream Industry in Middle East 2013-2017
Table Demand Volume of Biopharmaceuticals by Downstream Industry in Africa 2013-2017
Table Demand Volume Forecast of Biopharmaceuticals in EMEA by Downstream Industry 2018-2023
Table Sales Volume of Biopharmaceuticals in EMEA by Major Players 2013-2017
Table Revenue of Biopharmaceuticals in EMEA by Major Players 2013-2017
Table Headquarters Location and Established Time of Biopharmaceuticals Major Players
Table Employees and Revenue Level of Biopharmaceuticals Major Players
Table Representative Biopharmaceuticals Product One of Roche
Table Representative Biopharmaceuticals Product Two of Roche
Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Roche 2013-2017
Table Representative Biopharmaceuticals Product One of Amgen
Table Representative Biopharmaceuticals Product Two of Amgen
Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Amgen 2013-2017
Table Representative Biopharmaceuticals Product One of AbbVie
Table Representative Biopharmaceuticals Product Two of AbbVie
Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of AbbVie 2013-2017
Table Representative Biopharmaceuticals Product One of Sanofi-Aventis
Table Representative Biopharmaceuticals Product Two of Sanofi-Aventis
Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Sanofi-Aventis 2013-2017
Table Representative Biopharmaceuticals Product One of Johnson & Johnson
Table Representative Biopharmaceuticals Product Two of Johnson & Johnson
Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017
Table Representative Biopharmaceuticals Product One of Pfizer
Table Representative Biopharmaceuticals Product Two of Pfizer
Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017
Table Representative Biopharmaceuticals Product One of Novo Nordisk
Table Representative Biopharmaceuticals Product Two of Novo Nordisk
Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Novo Nordisk 2013-2017
Table Representative Biopharmaceuticals Product One of Eli Lilly
Table Representative Biopharmaceuticals Product Two of Eli Lilly
Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Eli Lilly 2013-2017
Table Representative Biopharmaceuticals Product One of Novartis
Table Representative Biopharmaceuticals Product Two of Novartis
Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Novartis 2013-2017
Table Representative Biopharmaceuticals Product One of Merck
Table Representative Biopharmaceuticals Product Two of Merck
Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Merck 2013-2017
Companies
- PRICE
-
$3480$5980